MiR-196a promoted cell migration, invasion and the epithelial-mesenchymal transition by targeting HOXA5 in osteosarcoma.

Cancer Biomarkers : Section a of Disease Markers
Xiaoli WangFang Zhang

Abstract

Osteosarcoma (OS), aggressive neoplasms of the bone, is the most common primary bone cancer in children. MiR-196a usually low expressed in several tumors and its functions in osteosarcoma still unclear. Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to assess the expression of miR-196a and the HOXA5. Cell metastasis and epithelial-mesenchymal transition (EMT) abilities were assessed using Transwell and western blot. The dual luciferase reporter assay was carried out to verify whether miR-196a directly targeted the 3'-untranslated region (UTR) of HOXA5 mRNA. MiR-196a was overexpressed and HOXA5 was low expressed in osteosarcoma versus the non-tumor tissues and normal cell lines. Upregulation of miR-196a or downregulation of HOXA5 was associated with worse outcome of osteosarcoma patients. MiR-196a enhanced cell migration, invasion and EMT by regulating the expression of HOXA5 through directly targeting the 3'-UTR of its mRNA in osteosarcoma. HOXA5 partially reversed roles of miR-196a on metastasis and EMT in osteosarcoma. MiR-196a promoted cell metastasis and EMT by targeting the 3'-UTR of HOXA5 mRNA in osteosarcoma. The newly identified miR-196a/HOXA5 axis provides novel insight into the pathogenesis of...Continue Reading

References

Sep 19, 2009·Nature Reviews. Genetics·Carlo M Croce
Jan 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mei-ling ZhangWei Li
May 30, 2015·Expert Opinion on Emerging Drugs·Claudia Maria HattingerMassimo Serra
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S IsakoffRichard Gorlick
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Sep 14, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yinan MaMinghua Bai
Dec 14, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hui ZhangZhi-Min Suo
Jan 10, 2017·Journal of Dental Research·X LuanT G H Diekwisch
Jan 18, 2017·Cancer Investigation·Mona FendereskiManoochehr Tavassoli
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 25, 2016·Journal of Developmental Biology·Lucie JeannotteKim Landry-Truchon
Jul 18, 2018·Oncology Reports·Xudong PengZiwei Wang
Nov 15, 2018·DNA and Cell Biology·Shaoxuan ZhangZhaohua Li
Feb 21, 2019·British Journal of Cancer·Michael J G MilevskiyMelissa A Brown

❮ Previous
Next ❯

Citations

Dec 9, 2020·Bioscience Reports·Mengqiu XiongBangshun He
Feb 19, 2021·Technology in Cancer Research & Treatment·Tao LiXin Zhang
Aug 18, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Zhi Xiong ChongWan Yong Ho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.